GAITHERSBURG, Md., Sept. 22, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the “Company”), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that findings from a comprehensive systematic review and meta-analysis (statistical pooling) of the use of platelet rich plasma (PRP) gel in wound healing were published online in ePlasty, the open-access journal of the Journal of Plastic Surgery. The article, entitled “Use of Platelet Rich Plasma Gel on Wound Healing: A Systematic Review and Meta-Analysis,” can be viewed at the ePlasty website at:
